A detailed history of Inter Ocean Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Inter Ocean Capital Group, LLC holds 68,921 shares of ABBV stock, worth $12.6 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
68,921
Previous 69,116 0.28%
Holding current value
$12.6 Million
Previous $10.7 Million 17.18%
% of portfolio
0.31%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $31,164 - $35,509
-195 Reduced 0.28%
68,921 $12.6 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $93,430 - $105,224
679 Added 0.99%
69,116 $10.7 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $128,513 - $148,773
962 Added 1.43%
68,437 $10.2 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $275,885 - $343,321
-2,082 Reduced 2.99%
67,475 $9.09 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $450,460 - $518,772
3,115 Added 4.69%
69,557 $11.1 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $182,569 - $218,948
-1,320 Reduced 1.95%
66,442 $10.7 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $6.34 Million - $7.28 Million
47,276 Added 230.77%
67,762 $9.09 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $1.29 Million - $1.64 Million
9,376 Added 84.39%
20,486 $3.14 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $93,045 - $115,443
705 Added 6.78%
11,110 $1.8 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $184,027 - $232,848
1,713 Added 19.71%
10,405 $1.41 Million
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $54,051 - $61,356
508 Added 6.21%
8,692 $938,000
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $37,770 - $42,078
359 Added 4.59%
8,184 $922,000
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $18,209 - $20,046
-178 Reduced 2.22%
7,825 $847,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $644,161 - $869,686
8,003 New
8,003 $857,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Inter Ocean Capital Group, LLC Portfolio

Follow Inter Ocean Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inter Ocean Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inter Ocean Capital Group, LLC with notifications on news.